MURAL - Maynooth University Research Archive Library

    Assessment of Dihydro[1,3]oxazine‐Fused Isoflavone and 4‐Thionoisoflavone Hybrids as Antibacterials

    Lathwal, Ankit and Ali, Asghar and Uddin, Amad and Khan, Nashra Shareef and Sheehan, Gerard and Kavanagh, Kevin and Haq, Qazi Mohd. Rizwanul and Abid, Mohammad and Nath, Mahendra (2021) Assessment of Dihydro[1,3]oxazine‐Fused Isoflavone and 4‐Thionoisoflavone Hybrids as Antibacterials. ChemistrySelect, 6 (29). pp. 7505-7513. ISSN 2365-6549

    Download (4MB) | Preview

    Share your research

    Twitter Facebook LinkedIn GooglePlus Email more...

    Add this article to your Mendeley library


    A series of isoflavone functionalized 3,4-dihydro-1,3-oxazine hybrids was synthesized in good to excellent yields through a Mannich-type condensation cyclization reaction of 6-chloro-7-hydroxy-3-(2-methoxy-phenyl)-chromen-4-one or 6-chloro-7-hydroxy-3-(2-methoxy-phenyl)-chromene-4-thione with formaldehyde and primary amines. After spectroscopic characterization, these newly prepared hybrids were evaluated for their antibacterial activities against two of each Gram positive (Staphylococcus aureus and Bacillus subtilis) and Gram negative (Escherichia coli and Pseudomonas aeruginosa) bacterial strains. Among the screened compounds, dihydro[1,3]oxazine-fused 4- thionoisoflavones(9band9c) exhibited potent inhibitory activity against all the tested bacterial species. Moreover, compound 9b possessed most promising antibacterial activity against P. aeruginosa and B. subtiliswith MIC 16 μg/mL and S. aureusand E.coliwith MIC 32 μg/mL. Further, 9bdemonstrated better efficacy (MIC=16 μg/mL) than the standard drug ampicillin (MIC= 32 μg/mL) against P. aeruginosaand it also found to be equipotent (MIC=16 μg/mL) as ampicillin against B. subtilis. Considering the disk diffusion and synergistic studies, 9be�merged asmost active compound showing potent activity against all the tested bacterial strains. In addition, no significant hemolysis or cytotoxicity was observed towards human embryonic kidney (HEK293)cells as well as Galleria mellonellalarvae (in vivo). Hence, compound 9bhas potential to be further explored alone and in combination with ampicillin as a next generation antibacterial agent.

    Item Type: Article
    Additional Information: Cite as: Lathwal, A., Ali, A., Uddin, A., Khan, N.S., Sheehan, G., Kavanagh, K., Haq, Q.M.R., Abid, M. and Nath, M. (2021) Assessment of Dihydro[1,3]oxazine-Fused Isoflavone and 4-Thionoisoflavone Hybrids as Antibacterials. ChemistrySelect, 6 (29), 7505-7513.
    Keywords: Thionoisoflavone Hybrids; Antibacterials;
    Academic Unit: Faculty of Science and Engineering > Biology
    Faculty of Science and Engineering > Research Institutes > Human Health Institute
    Item ID: 17326
    Identification Number:
    Depositing User: Dr. Kevin Kavanagh
    Date Deposited: 15 Jun 2023 12:11
    Journal or Publication Title: ChemistrySelect
    Refereed: Yes
    Use Licence: This item is available under a Creative Commons Attribution Non Commercial Share Alike Licence (CC BY-NC-SA). Details of this licence are available here

    Repository Staff Only(login required)

    View Item Item control page


    Downloads per month over past year

    Origin of downloads